All In Biotech

Drug Trial Radar · NCT05869903

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral Orforglipron Compared With Placebo in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)

Last checked: Nov 20, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 3,127 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

3,127

Actual

Start

Jun 5, 2023

Primary completion

Jul 25, 2025

Study completion Oct 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 22, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-related comorbidities. The study has two phases: a main phase and an extension phase. The main phase of the study lasted 72 weeks. Participants with prediabetes will continue in the extension for another 2 years.

Conditions

  • Obesity
  • Overweight
  • Overweight or Obesity

Interventions

  • OrforglipronDrug

    Administered orally.

  • PlaceboDrug

    Administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Body Weight (Primary Treatment Period)Time frame: Baseline, Week 72

Locations

138 sites in 10 countries. Site status is shown where the registry gives one.

  • The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

    Chandler, Arizona

  • Clinical Research Institute of Arizona (CRI) - Sun City West

    Sun City West, Arizona

  • John Muir Physician Network Research Center

    Concord, California

  • AMCR Institute

    Escondido, California

  • NorCal Medical Research, Inc

    Greenbrae, California

  • Velocity Clinical Research, Huntington Park

    Huntington Park, California

  • Velocity Clinical Research, Westlake

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Norcal Endocrinology & Internal Medicine

    San Ramon, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • New Age Medical Research Corporation

    Miami, Florida

  • South Broward Research

    Miramar, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Jedidiah Clinical Research - Tampa - Bay Plaza

    Tampa, Florida

  • Clinical Site Partners, LLC dba Flourish Research

    Winter Park, Florida

  • Physicians Research Associates

    Lawrenceville, Georgia

  • East Coast Institute for Research, LLC

    Macon, Georgia

  • Rophe Adult and Pediatric Medicine/SKYCRNG

    Union City, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Elite Clinical Trials

    Blackfoot, Idaho

  • Cotton O'Neil Clinical Research Center

    Topeka, Kansas

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Care Access - Lake Charles

    Lake Charles, Louisiana

  • MedStar Health Research Institute (MedStar Physician Based Research Network)

    Hyattsville, Maryland

  • Endocrine and Metabolic Consultants

    Rockville, Maryland

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • SKY Integrative Medical Center/SKYCRNG

    Ridgeland, Mississippi

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • Long Island Cardiovascular Consultants

    Lake Success, New York

  • Weill Cornell Medical College

    New York, New York

  • Alliance for Multispecialty Research, LLC

    Norman, Oklahoma

  • Texas Diabetes & Endocrinology, P.A.

    Austin, Texas

  • Thyroid, Endocrinology, and Diabetes

    Dallas, Texas

  • Velocity Clinical Research, Dallas

    Dallas, Texas

  • Cedar Health Research

    Dallas, Texas

  • Juno Research

    Houston, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • Soma Clinical Trials

    Wylie, Texas

Showing 40 of 138 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.